Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IM Olanzapine vs Haloperidol or Midazolam for Acute Agitation in ED
NCT02380118Phase 4Terminated
- Sponsor
- The University of Hong Kong
- Start
- Dec 2014
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of olanzapine (3 arms), sponsored by The University of Hong Kong. Primary endpoint: Time to achieve adequate sedation. Started Dec 2014; status: terminated.
02
Drugs
olanzapine
Beyond the preview
Go deeper on NCT02380118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02380118.